Literature DB >> 8347395

The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa.

R J Biggar1, J E Neequaye, A R Neequaye, G A Ankra-Badu, P H Levine, A Manns, M Taylor, J Drummond, D Waters.   

Abstract

We conducted a population-based serosurvey of urban areas and rural regions of southern Ghana, West Africa. Subjects (3763) of all ages were enrolled from 25 city and village sites and in studies of groups of special interest. "Positive" results were difficult to define because of a high frequency of results that were indeterminate on immunoblotting, the current standard for confirmation of HTLV-I. However, polymerase chain reaction results and HTLV type-specific discriminatory tests proved HTLV-I was present in Ghana. No HTLV-2 positivity was observed. By using strict criteria that considered indeterminate results as negative, the overall prevalence was found to be between 1 and 2% in all areas, with no difference by geographic location. Prevalence rose with age and was higher in adult women than men. However, in substudies of selected populations, we found HTLV prevalence among 124 persons with lymphomas and hematological malignancies was not different from that in the general population. Furthermore, the prevalence in prostitutes was similar to that in the general population and in pregnant women. HTLV-I is present in West Africa, but we were unable to associate HTLV-I seropositivity with malignancy or with prostitution.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Antibodies--analysis; Biology; Demographic Factors; Developing Countries; Diseases; English Speaking Africa; Epidemiologic Methods; Examinations And Diagnoses; Ghana; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Measurement; Physiology; Population; Population Characteristics; Prevalence; Research Methodology; Rural Population; Urban Population; Viral Diseases; Western Africa

Mesh:

Substances:

Year:  1993        PMID: 8347395     DOI: 10.1089/aid.1993.9.505

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  Assessment of a new immunoassay for serological confirmation and discrimination of human T-cell lymphotropic virus infections.

Authors:  M Zrein; J Louwagie; H Boeykens; L Govers; G Hendrickx; F Bosman; E Sablon; C Demarquilly; M Boniface; E Saman
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

2.  Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.

Authors:  R Mahieux; P Horal; P Mauclère; O Mercereau-Puijalon; M Guillotte; L Meertens; E Murphy; A Gessain
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

3.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

Review 4.  Seroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in Africa.

Authors:  James M Fox; Nora Mutalima; Elizabeth Molyneux; Lucy M Carpenter; Graham P Taylor; Martin Bland; Robert Newton; Fabiola Martin
Journal:  Trop Med Int Health       Date:  2016-02-03       Impact factor: 2.622

Review 5.  Re-emergence of human T-lymphotropic viruses in West Africa.

Authors:  Nneoma Confidence JeanStephanie Anyanwu; Elijah Ekah Ella; Aghogho Ohwofasa; Maryam Aminu
Journal:  Braz J Infect Dis       Date:  2018-06-05       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.